Research programme: NEXI 200 series - NexImmune
Alternative Names: NEXI 200; NEXI-200 series - NexImmuneLatest Information Update: 23 Aug 2023
At a glance
- Originator NexImmune
- Class
- Mechanism of Action T lymphocyte replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Autoimmune disorders
Most Recent Events
- 22 Aug 2023 Preclinical trials in Autoimmune disorders in USA (Parenteral) (NexImmune pipeline, August 2023)